Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvia Ceccarelli

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Immunologic Research|December 4, 2014
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literatureFabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Clinical and Experimental Medicine|April 10, 2024
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohortFulvia Ceccarelli, Francesco Natalucci, Licia Picciariello, et al.
Journal of Immunology Research|January 3, 2022
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian PopulationAndrea Latini, Giada De Benedittis, Carlo Perricone, et al.
Plos One|November 5, 2014
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 geneCinzia Ciccacci, Carlo Perricone, Fulvia Ceccarelli, et al.
Plos One|October 3, 2012
Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up studyFabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Frontiers in Immunology|January 21, 2025
Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot studySimona Truglia, Francesco Ciccia, Silvia Mancuso, et al.
Clinical and Experimental Rheumatology|September 21, 2012
The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritisFulvia Ceccarelli, Sandra D'Alfonso, Carlo Perricone, et al.
Plos One|September 17, 2013
Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indicesFabrizio Conti, Fulvia Ceccarelli, Laura Massaro, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational studyRossana Scrivo, Chiara Castellani, Silvia Mancuso, et al.
Plos One|March 23, 2017
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Immunologic Research|December 4, 2014
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literatureFabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Clinical and Experimental Medicine|April 10, 2024
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohortFulvia Ceccarelli, Francesco Natalucci, Licia Picciariello, et al.
Journal of Immunology Research|January 3, 2022
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian PopulationAndrea Latini, Giada De Benedittis, Carlo Perricone, et al.
Plos One|November 5, 2014
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 geneCinzia Ciccacci, Carlo Perricone, Fulvia Ceccarelli, et al.
Plos One|October 3, 2012
Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up studyFabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Frontiers in Immunology|January 21, 2025
Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot studySimona Truglia, Francesco Ciccia, Silvia Mancuso, et al.
Clinical and Experimental Rheumatology|September 21, 2012
The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritisFulvia Ceccarelli, Sandra D'Alfonso, Carlo Perricone, et al.
Plos One|September 17, 2013
Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indicesFabrizio Conti, Fulvia Ceccarelli, Laura Massaro, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational studyRossana Scrivo, Chiara Castellani, Silvia Mancuso, et al.
Plos One|March 23, 2017
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Pageof 20